Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study for Subretinal Injection of NGGT001 in Patients With Bietti Crystalline Corneoretinal Dystrophy

NCT06706427 is registered in ClinicalTrials.gov with NGGT (Suzhou) Biotechnology Co., Ltd. as lead sponsor.

NCT NCT06706427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06706427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study for Subretinal Injection of NGGT001 in Patients With Bietti Crystalline Corneoretinal Dystrophy
Lead sponsor
NGGT (Suzhou) Biotechnology Co., Ltd.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
March 21, 2024
Completion date
September 26, 2029
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bietti crystalline corneoretinal dystrophy